Editors: Carla Rossi, Susanna Conti

Evaluating the impact of Laws Regulating Illicit Drugs on Health and Society

eBook: US $59 Special Offer (PDF + Printed Copy): US $101
Printed Copy: US $71
Library License: US $236
ISBN: 978-981-5079-25-8 (Print)
ISBN: 978-981-5079-24-1 (Online)
Year of Publication: 2023
DOI: 10.2174/97898150792411230101

Introduction

Evaluating the impact of Laws Regulating Illicit Drugs on Health and Society serves as an informative reference for social science researchers and policymakers on the science behind drug regulation.

The book presents contributions from many leading researchers in drug law and policy evaluation. The 12 chapters highlight scientific evidence from a diverse range of international projects on evaluation of different illicit drug laws. Each contribution takes policies into account while also using methodological tools and relevant data sets.

For a priori evaluation, the modern leximetric approach is applied to compare different drug laws. For posterior evaluation the analysis of social and health outcomes, using standard and new indicators are presented, discussed and applied. Next, the book covers the use of drug market estimation methods in policy research. Specific new indicators allowing the evaluation of interventions such as harm reduction and prevention are presented and analysed using international research data. The book concludes with a summary of the links of illegal drug market gains with corruption, and its consequences.

Evaluating the impact of Laws Regulating Illicit Drugs on Health and Society gives readers a unique, evidence-based perspective on the relationship between drugs, laws, policy and socioeconomic conditions.

Key Features

1. Features 12 contributions from international experts on drug legislation and social science

2. Demonstrates evidence-based evaluation of drug laws and policies

3. Highlights Leximetric and forecast methods applied to illicit drug laws with examples

4. Highlights the use of standard and new socioeconomic indicators to evaluate drug laws and policies

5. Informs readers about different policy approaches to drug regulation and their consequences

6. Summarizes the links of illegal drug markets with corruption

7. Provides detailed references for further reading

Audience:

Social science researchers, economists, drug regulators, and policymakers

Contributors

Editor(s):
Carla Rossi
Centre of Statistical and Social Studies (Ce3S)
Rome
Italy


Susanna Conti
Società di Statistica Medica ed
ed Epidemiologia Clinica (SISMEC)





Contributor(s):
Andre Noor
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
Lisbon
Portugal


Andrew Cunningham
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
Lisbon
Portuga


Alice Maraschini
Statistical Service
Istituto Superiore di Sanità
Viale Regina Elena 299, 00185 Rome
Italy


Christopher Hallam
Independent Researcher and Research Associate
Global Drug Policy Observatory


Carla Rossi
Centre for Statistical and Social Studies
Rome
Italy


Catherine Maria Comiskey
School of Nursing and Midwifery
Trinity College
Dublin
Ireland


Calum Griffiths
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
Lisbon
Portugal


Elizabeth Mary McCarthy
School of Nursing and Midwifery
Trinity College
Dublin
Ireland


Frank Zobel
Addiction Suisse
Lausanne
Switzerland


Francesca De Marinis
Judge (magistrato di sorveglianza)
Naples
Italy


Francesco Fabi
Centre for Statistical and Social Studies
Rome
Italy


Gillian Kolla
Canadian Institute for Substance Use Research
University of Victoria
2300 McKenzie Ave
Victoria, BCV8N 5M8


Giada Minelli
Statistical Service
Istituto Superiore di Sanità
Viale Regina Elena 299, 00185 Rome
Italy


Gordon Hay
Liverpool John Moores University
Liverpool
UK


Jeanette Bowles
Centre on Drug Policy Evaluation
Li Ka Shing Knowledge Institute
St. Michael’s Hospital, Toronto, Ontario
Canada
/
Project SAFE Philadelphia
Philadelphia
Pennsylvania
United States


Luca Di Censi
Human Foundation Do & Think Tank per l’Innovazione Sociale
Rome
Italy


Luis Royuela
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
Lisbon
Portuga


Muhammad Zaid Dauhoo
Department of Mathematics, Faculty of Science
University of Mauritius
Reduit
Mauritius


Nazlee Maghsoudi
Centre on Drug Policy Evaluation
Li Ka Shing Knowledge Institute
St. Michael’s Hospital, Toronto
Canada
/
Institute of Health Policy
Management and Evaluation, University of Toronto
Toronto, Ontario
Canada


Nicola Singleton
Visiting researcher
National Addiction Centre
IoPPN, King’s College London
UK


Pierre Esseiva
School of Criminal Justice
University of Lausanne
Switzerland


Paul Griffiths
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
Lisbon
Portuga


Robin Udrisard
Addiction Suisse
Lausanne
Switzerland


Roumen Sedefov
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
Lisbon
Portuga


Samantha Young
Division of General Internal Medicine
Department of Medicine, St. Michael’s Hospital, Unity Health
Toronto, Ontario
Canada
/
Institute of Health Policy
Management and Evaluation, University of Toronto
Toronto, Ontario
Canada
/
Interdepartmental Division of Addiction Medicine, Vancouver
St. Paul’s Hospital
British Columbia
Canada


Sarah Griffiths
Division of General Internal Medicine
Department of Medicine, St. Michael’s Hospital, Unity Health
Toronto, Ontario
Canada


Susanna Conti
Società di Statistica
Medica ed Epidemiologia Clinica (SISMEC)
Milan
Italy


Teodora Groshkova
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
Lisbon
Portugal


Yusra Bibi Ruhomally
Department of Mathematics, Faculty of Science
University of Mauritius
Reduit
Mauritius


Valerio Manno
Statistical Service
Istituto Superiore di Sanità
Viale Regina Elena 299, 00185 Rome
Italy


Zoe Swithenbank
Liverpool John Moores University
Liverpool
UK